Description
What is Type 2 Finca Serum for Rosacea?
Type 2 serum is the best Cream For Type 2 Rosacea, type 2 serum includes a unique formulation for targeting the pustules/bumps and pimples associated with type 2 rosacea, also known as acne rosacea. It has a clean plant, based formulation product without the use of chemicals which can further irritate rosacea type 2 skin. Also it helps reduce Rhinophyma Symptoms By helping to cleanse the face of sebum – the oily substance produced by the sebaceous glands to help hydrate our skin – the type-2 rosacea serum is also very effective at helping rhinophyma sufferers. People with rhinophyma produce too much sebum, which can lead to swelling of the nose.
What Makes Our Serum So Effective?
The finca serum is the best selling product of the finca range. Its active ingredients tea tree and oil of oregano are formulated in a gentle serum also containing zinc oxide for healing and licorice root. Licorice roots main component glycyrrhizinate has been proven time and time again to be an effective anti-inflammatory and moisturizer. Typically our customers see results within 3 weeks of constant use. With 40% reduction in overall redness, bumps, pustules and pimples within 6 weeks and continuing improvements in the skin after that. Usually after 12 weeks only maintenance is needed with application reduced from twice a day to once only- last thing at night. The Science Behind Our Formula Evidence is mounting, that an overabundance of Demodex mites on the face, may trigger an immune response in people with rosacea, or that the inflammation may be caused by bacteria associated with the mites. The mites are most plentiful in the same regions of the face that are most commonly affected by rosacea — the cheeks, nose, chin and forehead — and that large quantities of mites have been found in biopsies of rosacea papules and pustules.
Topical Cream For Acne Rosacea: Targets Pustules And Bumps
Visible Reduction in pustules and bumps
Reduced facial redness
Reduced swelling
All natural ingredients in patent pending formulation